Peer-reviewedCC BYBMJ open
Preferences for treatment for latent tuberculosis infection in primary care among people in the USA at increased risk of tuberculosis: a pilot survey.
10 affiliations
- 1Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, USA [email protected].
- 2Center for Tuberculosis, University of California San Francisco, San Francisco, California, USA.
- 3North East Medical Services, San Francisco, California, USA.
- 4Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, USA.
- 5Tuberculosis Control Branch, California Department of Public Health, Richmond, California, USA.
- 6Division of Hospital Medicine, University of California San Francisco, San Francisco, California, USA.
- 7Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- 8Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, USA.
- 9Department of Social and Behavioral Sciences, Institute for Health & Aging, University of California San Francisco, San Francisco, California, USA.
- 10Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, USA.
Related
- Determinants of willingness to accept Tuberculosis Preventive Treatment (TPT) among close contacts with Tuberculosis Infection (TBI) in Xinjiang, China
- Barriers and facilitators of implementing a latent tuberculosis infection (LTBI) case management program in a primary care setting
- Latent tuberculosis infection in focus: Evaluating public concerns, treatment perceptions, and awareness in King Sabatha Dalindyebo Local Municipality, Eastern Cape, South Africa
- Adaptive immunity shapes baseline physiology of M. tuberculosis in high-dose versus low-dose infection BALB/c mouse drug treatment models
- Defining use cases for biomarkers and tests across tuberculosis infection, disease and treatment: An international consensus and prioritisation exercise
BibTeX
@article{aschmann2026preferences,
title = {{Preferences for treatment for latent tuberculosis infection in primary care among people in the USA at increased risk of tuberculosis: a pilot survey.}},
author = {Hélène E Aschmann and Amy S Tang and Meagan Lee and Katya L Salcedo and Matthew T Murrill and Gina Chen and Yuqian Ouyang and Kit Lui and Mehabuba Rahman and Jennifer Flood and Andrew D Kerkhoff and Tracy K Lin and Priya B Shete and Tuberculosis Epidemiologic Studies Consortium},
journal = {BMJ open},
year = {2026},
month = oct,
doi = {10.1136/bmjopen-2026-121108},
url = {https://europepmc.org/article/MED/42880810},
note = {CC BY},
}
RIS
TY - JOUR
TI - Preferences for treatment for latent tuberculosis infection in primary care among people in the USA at increased risk of tuberculosis: a pilot survey.
AU - Hélène E Aschmann
AU - Amy S Tang
AU - Meagan Lee
AU - Katya L Salcedo
AU - Matthew T Murrill
AU - Gina Chen
AU - Yuqian Ouyang
AU - Kit Lui
AU - Mehabuba Rahman
AU - Jennifer Flood
AU - Andrew D Kerkhoff
AU - Tracy K Lin
AU - Priya B Shete
AU - Tuberculosis Epidemiologic Studies Consortium
PY - 2026
DA - 2026/10/14
JO - BMJ open
DO - 10.1136/bmjopen-2026-121108
UR - https://europepmc.org/article/MED/42880810
SN - 2044-6055
ER -